2m 2m 2m 2m 2m 2m 2m
STERIS (STE)
NYSE
$200.00-$0.40 (-0.20%)
Price as of Jun 23, 2026 7:05 PM EDT- $19.5BMarket Cap
- -14.51%1-Year Change
- Medical DevicesIndustry
STERIS (STE)
$200.00-$0.40 (-0.20%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.1B +6.56% | 2.9B -44.12% | 5.1B +3.65% | 5.0B +8.13% | |
Cost of Revenue | 1.6B +7.35% | 1.5B -48.15% | 2.9B +4.37% | 2.8B +8.93% | |
Gross Profit | 2.6B +9.31% | 2.4B +8.32% | 2.2B +2.71% | 2.2B +7.11% | |
Sales and Marketing Expense | 1.4B +5.50% | 1.3B +6.54% | 1.3B -3.58% | 1.3B -13.57% | |
Research and Development Expense | -112.9M +4.88% | -107.6M +3.83% | -103.7M -202.07% | 101.6M +15.51% | |
Depreciation and Amortization Expense | 486.5M +2.16% | 476.2M -15.75% | 565.2M +2.23% | 552.9M -0.04% | |
Total Operating Expenses | 1.5B -0.74% | 1.5B +11.15% | 1.4B -26.93% | 1.9B +18.91% | |
Operating Profit | 1.1B +27.13% | 866.6M +3.65% | 836.1M +211.77% | 268.2M -36.99% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -144.4M +33.67% | -108.0M +20.53% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -144.4M -233.67% | 108.0M +20.53% | |
Total Nonoperating Income and Expense | -54.4M -22.76% | -70.4M -47.16% | -133.3M +20.27% | -110.8M -0.25% | |
Income before Taxes | 1.0B +31.54% | 796.2M +13.29% | 702.8M +346.66% | 157.3M -49.97% | |
Income Taxes | 262.2M +42.00% | 184.7M +23.49% | 149.5M +190.15% | 51.5M -28.06% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 782.3M +27.28% | 614.6M +62.50% | 378.2M +253.40% | 107.0M -56.12% | |
Net Income from Continuing Operations Applicable to Common | 1.0B +31.54% | 796.2M +13.29% | 702.8M +346.66% | 157.3M -49.97% | |
Basic EPS and Net Income | 7.97 +27.72% | 6.24 +62.92% | 3.83 +257.94% | 1.07 -57.20% | |
Diluted EPS and Net Income | 7.93 +27.90% | 6.20 +62.73% | 3.81 +256.07% | 1.07 -56.85% | |
Basic Weighted Average Shares | 98.2M -0.38% | 98.6M -0.21% | 98.8M -0.92% | 99.7M +2.23% | |
Diluted Weighted Average Shares | 98.7M -0.37% | 99.1M -0.29% | 99.4M -0.88% | 100.2M +1.95% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 439.6M +156.03% | 171.7M -17.06% | 207.0M -0.64% | 208.4M -40.18% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 439.6M +156.03% | 171.7M -17.06% | 207.0M -0.64% | 208.4M -40.18% | |
Total Current Assets | 2.4B +19.68% | 2.0B -30.27% | 2.9B +42.64% | 2.0B +7.05% | |
Accumulated Depreciation | 1.9B +12.33% | 1.7B +9.99% | 1.6B +10.14% | 1.4B +12.86% | |
Property and Plant and Equipment and Net | 2.2B +10.46% | 2.0B +10.84% | 1.8B +3.50% | 1.7B +9.85% | |
Total Long-Term Assets | 211.4M +154.56% | 83.0M +25.45% | 66.2M -15.29% | 78.1M +10.59% | |
Total Assets | 10.7B +5.82% | 10.1B -8.29% | 11.1B +2.23% | 10.8B -5.27% | |
Income Taxes Payable | 28.6M +33.30% | 21.5M +57.30% | 13.6M -68.86% | 43.8M +63.00% | |
Total Short-Term Debt | 118.9M -4.88% | 125.0M +45.45% | 85.9M +43.23% | 60.0M -58.01% | |
Total Current Liabilities | 1.1B +12.02% | 1.0B +9.78% | 931.1M +8.04% | 861.8M -6.55% | |
Total Long-Term Debt | 1.8B -5.52% | 1.9B -38.51% | 3.1B +3.36% | 3.0B +2.48% | |
Total Long-Term Liabilities | 71.7M +15.85% | 61.9M -13.50% | 71.5M -6.03% | 76.1M +0.74% | |
Total Liabilities | 3.5B +0.25% | 3.5B -25.64% | 4.7B +0.29% | 4.7B -2.96% | |
Retained Earnings | 3.0B +21.84% | 2.5B +18.57% | 2.1B +9.21% | 1.9B -4.39% | |
Total Stockholders Equity | 7.2B +8.79% | 6.6B +4.78% | 6.3B +3.70% | 6.1B -6.97% | |
Total Shares Outstanding | 97.8M -0.51% | 98.3M -0.59% | 98.9M +0.26% | 98.6M -1.44% | |
Cash Flow | |||||
Cash from Operating Activities | 1.3B +16.84% | 1.1B +17.96% | 973.3M +28.58% | 756.9M +10.53% | |
Capital Expenditures | 369.0M -0.29% | 370.1M +2.71% | 360.3M -0.45% | 362.0M +25.87% | |
Cash from Investing Activities | -512.5M -231.82% | 388.8M +143.81% | -887.4M +131.49% | -383.3M -42.49% | |
Dividends Paid | 241.8M +9.97% | 219.9M +9.63% | 200.6M +9.30% | 183.5M +12.46% | |
Cash from Financing Activities | -568.2M -63.86% | -1.6B +1,745.80% | -85.2M -82.92% | -498.7M -530.56% | |
Financials Ratio | |||||
Gross Margin | 46.88% -0.82% | 47.27% +9.50% | 43.17% -0.91% | 43.56% -0.94% | |
Operating Margin | 36.01% +19.30% | 30.18% +85.48% | 16.27% +200.80% | 5.41% -41.73% | |
Return on Assets | 7.49% +29.27% | 5.80% +67.67% | 3.46% +259.19% | 0.96% -64.49% | |
Return on Equity | 11.35% +19.14% | 9.53% +55.87% | 6.11% +259.97% | 1.70% -63.76% | |
Revenue Growth | 6.56% +114.88% | -44.12% -1,309.38% | 3.65% -55.13% | 8.13% -82.90% | |
Current Ratio | 2.09 +6.85% | 1.96 -36.47% | 3.08 +32.02% | 2.33 +14.55% | |
Cash Ratio | 0.38 +128.51% | 0.17 -24.43% | 0.22 -8.06% | 0.24 -35.98% | |
Debt-to-Equity Ratio | 0.27 -13.12% | 0.31 -39.16% | 0.51 +0.41% | 0.51 +7.15% | |
Debt-to-Assets Ratio | 0.18 -10.68% | 0.20 -30.50% | 0.29 +1.86% | 0.28 +5.25% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow